ClearNote Health

United States - San Diego, California

• 28/05/2026
• Series D
• $52,000,000

ClearNote Health – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives.

We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops.

With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally.

#biotechnology #epigenomics #oncology #cancerresearch #cancer

Related People

Dave MullarkeyFounder

United States - Menlo Park, California

I build strategies to drive growth and profitability in demanding and complex markets, guide efforts across product development, business development and commercial while thriving in chaotic environments, bringing stability and a path forward to favorable outcomes. I deliver shareholder value growth and build investor and stakeholder relationships to enable fundraising, critical to fostering scalability. As a calculated risk taker, I empower team members to overcome business challenges and deliver results from R&D to commercialization stages of products/services. I utilize strategic thinking and deep market understanding and identify new revenue growth opportunities. I establish and execute against strategic priorities for multi-faceted organizations, while leading large, diverse teams and building positive corporate culture.

LinkedIn https://www.linkedin.com/in/dave-mullarkey/